Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

RECRUITING

Behavioral and Neural Characteristics of Adaptive Speech Motor Control

Lead Sponsor:

University of Washington

Collaborating Sponsors:

National Institutes of Health (NIH)

National Institute on Deafness and Other Communication Disorders (NIDCD)

Conditions:

Speech

Eligibility:

All Genders

4+ years

Phase:

NA

Brief Summary

This study meets the NIH definition of a clinical trial, but is not a treatment study. Instead, the goal of this study is to investigate how hearing ourselves speak affects the planning and execution ...

Eligibility Criteria

Inclusion

  • General inclusion criteria:
  • native speaker of American English
  • no communication or neurological problems (except for subjects in the DBS group)
  • 250-4000 Hz pure tone hearing thresholds equal to or better than 25 dB HL for children and young adults and equal to or better than 35 dB HL for older adults
  • no medications that affect sensorimotor functioning (except for in the DBS group)
  • adult subjects: 18 years of age or older
  • typical children: 4;0 to 6;11 \[years;months\] or 10;0 to 12;11 \[years;months\])
  • Specific inclusion criteria for children:
  • \* scoring above the 20th percentile on the Peabody Picture Vocabulary Test (PPVT-5), Expressive Vocabulary Test (EVT-3), Goldman-Fristoe Test of Articulation (GFTA-3), and either Test of Early Language Development (TELD-4) or (for children age 8 or older) Clinical Evaluation of Language Fundamentals (CELF-5).
  • Specific inclusion criteria for DBS patients:
  • \* bilateral electrodes implanted in either the ventral intermediate nucleus of the thalamus (Vim; a target site for patients with essential tremor) or subthalamic nucleus (STN; a target site for patients with Parkinson's disease)

Exclusion

    Key Trial Info

    Start Date :

    January 1 2023

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 31 2027

    Estimated Enrollment :

    507 Patients enrolled

    Trial Details

    Trial ID

    NCT06164717

    Start Date

    January 1 2023

    End Date

    December 31 2027

    Last Update

    December 11 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University of Washington

    Seattle, Washington, United States, 98105